Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia (Q59624472)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 June 2007
edit
Language Label Description Also known as
English
Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
scientific article published on 26 June 2007

    Statements

    title
    Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17595355
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17595355%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    1 January 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q59624472&oldid=2135119284"